Invivyd (IVVD) Market Capitalization (2021 - 2026)
Invivyd's (IVVD) quarterly Market Capitalization came in at $256.4 million in Q2 2026, up 200.62% on a YoY basis from $85.3 million in Q2 2025, and down 39.71% quarter-over-quarter from $425.4 million in Q4 2025.
Analysis
Invivyd (IVVD) Market Capitalization (2021 - 2026) Analysis & Trends
Invivyd (IVVD) has reported Market Capitalization for 6 consecutive years, with $256.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Market Capitalization rose 200.62% year-over-year to $256.4 million; the trailing twelve-month figure through Jun 2026 stood at $256.4 million (up 200.62% YoY), and the FY2025 full-year result was $425.4 million, up 706.73% from the prior year.
- Market Capitalization eased to $256.4 million in Q2 2026 per IVVD's latest filing, from $425.4 million in the prior quarter.
- Across five years, Market Capitalization topped out at $529.3 million in Q1 2024 and bottomed at $52.7 million in Q4 2024.
- Historically, Market Capitalization has averaged $240.7 million across 5 years, with a median of $186.7 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Market Capitalization sank 87.85% in 2024, then surged 706.73% in 2025.
- Over 5 years, Market Capitalization stood at $163.6 million in 2022, then jumped by 165.36% to $434.0 million in 2023, then tumbled by 87.85% to $52.7 million in 2024, then soared by 706.73% to $425.4 million in 2025, then plunged by 39.71% to $256.4 million in 2026.
- According to Business Quant data, Market Capitalization over the past three periods registered $256.4 million, $425.4 million, and $187.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Invivyd | 244.65 Mn | 84.57 Mn | 13.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 256.44 Mn |
| Dec 31, 2025 | 425.37 Mn |
| Sep 30, 2025 | 187.19 Mn |
| Jun 30, 2025 | 85.30 Mn |
| Mar 31, 2025 | 73.18 Mn |
| Dec 31, 2024 | 52.73 Mn |
| Sep 30, 2024 | 122.00 Mn |
| Jun 30, 2024 | 131.39 Mn |
| Mar 31, 2024 | 529.34 Mn |
| Dec 31, 2023 | 434.03 Mn |
| Sep 30, 2023 | 186.74 Mn |
| Jun 30, 2023 | 115.05 Mn |
| Mar 31, 2023 | 131.18 Mn |
| Dec 31, 2022 | 163.57 Mn |
| Sep 30, 2022 | 341.04 Mn |
| Jun 30, 2022 | 356.80 Mn |
| Mar 31, 2022 | 500.12 Mn |
| Dec 31, 2021 | 309.43 Mn |
| Sep 30, 2021 | 2.59 Bn |